{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T17:01:45Z","timestamp":1781974905420,"version":"3.54.5"},"reference-count":43,"publisher":"Wiley","license":[{"start":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T00:00:00Z","timestamp":1633305600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2018YFC1707407"],"award-info":[{"award-number":["2018YFC1707407"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Evidence-Based Complementary and Alternative Medicine"],"published-print":{"date-parts":[[2021,10,4]]},"abstract":"<jats:p>Introduction. Atopic dermatitis (AD) and diarrhea-predominant irritable bowel syndrome (IBS-D) are two recurrent diseases with limited effective treatments. In Chinese Medicine (CM) theory, they may share dampness pattern as the same dominant pathogenesis at a certain stage and, thus, can be treated with the same method. While Chinese herbal formula Huoxiang Zhengqi (HXZQ) has been reported as an effective dampness-resolving therapy for both AD and IBS-D, further high-quality clinical studies are still needed. In addition, HXZQ lacks accurate clinical positioning based on CM patterns. Therefore, we utilize a master protocol design to evaluate HXZQ for dampness pattern simultaneously in AD and IBS-D, with the aim of identifying the pattern-defined population of HXZQ. Methods and Analysis. This master protocol design includes two randomized controlled trials (RCTs) and a real-world observational study. Based on two registry cohorts of AD and IBS-D, patients with dampness pattern will be enrolled in the RCTs to receive either HXZQ oral liquid or a placebo for 4 weeks and then will be followed up for another 4 weeks, while patients with nondampness pattern will constitute the observational study and experience a 12-week follow-up. A total of 678 AD patients and 322 IBS-D patients will be recruited from 14 hospitals in China over a 3-year period. The eczema area and severity index (EASI) and the proportion of responders for adequate relief (AR) are the primary outcomes in AD and IBS-D, respectively. Analysis will be undertaken separately in each substudy, and then an overall analysis combining multiple subgroups will be performed to comprehensively investigate the effect of HXZQ. Discussion. This study will provide high-quality efficacy evidence of HXZQ for AD and IBS-D patients and give an example of postmarketing evaluation for CM products under the pattern dominating different disease research model. The study is registered with ChiCTR1900026700 and ChiCTR1900026837.<\/jats:p>","DOI":"10.1155\/2021\/5125568","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T23:01:44Z","timestamp":1633388504000},"page":"1-10","source":"Crossref","is-referenced-by-count":5,"title":["Chinese Herbal Formula Huoxiang Zhengqi for Dampness Pattern in Atopic Dermatitis and Diarrhea-Predominant Irritable Bowel Syndrome: Rationale and Design of a Master Protocol"],"prefix":"10.1155","volume":"2021","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5447-2770","authenticated-orcid":true,"given":"Qian","family":"Huang","sequence":"first","affiliation":[{"name":"Second Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou 510120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1547-3789","authenticated-orcid":true,"given":"Xiaohui","family":"Guo","sequence":"additional","affiliation":[{"name":"Key Unit of Methodology in Clinical Research, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China"},{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6775-1488","authenticated-orcid":true,"given":"Meiling","family":"Xuan","sequence":"additional","affiliation":[{"name":"Key Unit of Methodology in Clinical Research, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China"},{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5070-6365","authenticated-orcid":true,"given":"Wenwei","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Key Unit of Methodology in Clinical Research, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China"},{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1797-2047","authenticated-orcid":true,"given":"Zehuai","family":"Wen","sequence":"additional","affiliation":[{"name":"Key Unit of Methodology in Clinical Research, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China"},{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China"},{"name":"Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039803"},{"key":"2","article-title":"Research on the incidence and clinical characteristics of atopic dermatitis adults in third-grade first-class hospitals in China","author":"X. Wang"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2021.03.019"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2016.1214673"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.01.019"},{"key":"6","first-page":"615","volume-title":"ROME IV Drossman. Functional Gastrointestinal Disorders Disorders of Gut-Brain Interaction","author":"A. Douglas","year":"2016"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0292-7"},{"issue":"5","key":"8","first-page":"299","article-title":"Chinese expert consensus of irritable bowel syndrome in 2015","volume":"36","year":"2016","journal-title":"Chinese Journal of Digestive Diseases"},{"issue":"04","key":"9","first-page":"532","article-title":"Systematic review of IBS-D treated by Chinese herbal medicine","volume":"24","author":"D. M. Su","year":"2009","journal-title":"CJTCMP"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1007\/s11655-019-3030-x"},{"issue":"11","key":"11","first-page":"2397","article-title":"Analysis on regularity of TCM syndromes and Chinese herbs application for eczema","volume":"31","author":"C. Y. Zhang","year":"2013","journal-title":"Chinese Archives of TCM"},{"issue":"8","key":"12","first-page":"1183","article-title":"Cluster analysis and characteristics of syndrome on IBS-D:A study of 360 cases","volume":"25","author":"S. S. Zhang","year":"2010","journal-title":"CJTCMP"},{"issue":"5","key":"13","first-page":"218","article-title":"Case report of Huoxiang Zhengqi powder used in pediatrics","volume":"12","author":"L. P. Qin","year":"2010","journal-title":"Liaoning University of Traditional Chinese Medicine"},{"issue":"21","key":"14","first-page":"181","article-title":"Novel therapeutic application of Huoxiang Zhengqi liquid for skin disease","volume":"4","author":"G. R. Shi","year":"2010","journal-title":"Chinese Journal of Modern Drug Application"},{"issue":"3","key":"15","first-page":"31","article-title":"Clinical study of jiawei huoxiang zhengqi powder combined with western medicine for treatment of diarrhea-predominant irritable bowel syndrome","volume":"43","author":"G. H. Qiu","year":"2011","journal-title":"Journal of New Chinese Medicine"},{"key":"16","first-page":"376","article-title":"Observation on treatment of 58 cases of diarrhea-type irritable bowel syndrome with huoxiang zhengqi powder plus prescription","volume":"5","author":"F. K. Cao","year":"2003","journal-title":"Clinical Journal of Anhui Traditional Chinese Medicne"},{"key":"17","volume-title":"Intervention of Huoxiang Zhengqi Oral Liquid on Metabonomics and Intestinal Flora of Dampness Trapped Spleen Stomach Syndrome","author":"C. Y. Li","year":"2018"},{"issue":"5","key":"18","first-page":"1190","article-title":"Effect of Huoxiang Zhengqi powder on immune and metabolic function of sub-health animals with dampness stagnation of spleen and stomach","volume":"22","author":"Y. Liu","year":"2011","journal-title":"Lishizhen Medicine and Materia Medica Research"},{"issue":"4","key":"19","first-page":"391","article-title":"Effects of huoxiang zhengqi oral liquid on gut microbiota in rats with dampness obstructing spleen-stomach syndrome based on high-throughput 16S rRNA gene sequencing","volume":"30","author":"M. J. Gong","year":"2019","journal-title":"Traditional Chinese Drug Research & Clinical Pharmacology"},{"key":"20","volume-title":"Pharmacopoeia of the People\u2019s Republic of China 2015 Edition","author":"Chinese Pharmacopoeia commission","year":"2015"},{"key":"21","article-title":"Guidance for industry: codevelopment of two or more new investigational drugs for use in combination","author":"US FDA Center for Drug Evaluation and Research","year":"2013"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra1510062"},{"issue":"3","key":"23","first-page":"5","article-title":"Thoughts on researches under the pattern dominating disease","volume":"29","author":"Y. M. Jiao","year":"2011","journal-title":"Journal of Traditional Chinese Medical Literature"},{"key":"24","first-page":"2552","article-title":"Syndrome dominating disease-return and innovation of clinical thinking in traditional Chinese medicine","volume":"14","author":"H. Li","year":"2019","journal-title":"World Chinese Medicine"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-020-05014-6"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05444-w"},{"key":"27","first-page":"5","article-title":"Guideline for diagnosis and treatment of atopic dermatitis in China (2011)","volume":"1","author":"Atopic Dermatitis Working Group","year":"2011","journal-title":"Chinese Journal of Dermatology"},{"key":"28","volume-title":"Standard of Diagnosis and Curative Effect of Chinese Medicine Syndrome and Diseases","author":"State Administration of Traditional Chinese Medicine","year":"1994"},{"issue":"4","key":"29","article-title":"The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials","volume":"134","author":"S. Jochen","year":"2014","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2013.825314"},{"key":"31","article-title":"ICH Harmonised Tripartite Guideline"},{"key":"32","volume-title":"The Use of the WHO-UMC System for Standardised Case Causality Assessment","author":"WHO","year":"2018"},{"issue":"13","key":"33","first-page":"3009","article-title":"Study on the stage distribution regularity of TCM syndromes in different eczema","volume":"33","author":"H. X. Mu","year":"2013","journal-title":"Chinese Journal of Gerontology"},{"key":"34","volume-title":"The TCM Syndromes and Clinical Epidemiological Study of Irritable Bowel Syndrome","author":"M. Li","year":"2012"},{"issue":"4","key":"35","first-page":"592","article-title":"Review of research on information processing methods of medical effectiveness evaluation in the real world","volume":"20","author":"H. X. Ji","year":"2018","journal-title":"World Science and Technology-Modernization of Traditional Chinese Medicine and Materia Medica"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1136\/acupmed-2017-011527"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2015.07.009"},{"issue":"8","key":"38","first-page":"2010","article-title":"Application of umbrella design and basket design in evidence-based research for traditional Chinese medicine","volume":"46","author":"X. H. Guo","year":"2021","journal-title":"China Journal of Chinese Materia Medica"},{"key":"39","first-page":"111","article-title":"Design method of master protocol of clinical study on diseases of same syndrome type in Chinese medicine","volume":"59","author":"C. Zhao","year":"2018","journal-title":"Journal of Traditional Chinese Medicine"},{"key":"40","first-page":"102","article-title":"Master protocol applied to the prevention and treatment of Traditional Chinese Medicine for coronary heart disease: ideas and methods of evidence-based optimization","volume":"19","author":"J. Y. Hu","year":"2019","journal-title":"Chinese Journal of Evidence-Based Medicine"},{"issue":"5","key":"41","first-page":"705","article-title":"Research and development of evaluation methods of clinical symptoms of traditional Chinese medicine","volume":"20","author":"J. Cui","year":"2014","journal-title":"Journal of Basic Chinese Medicine"},{"issue":"10","key":"42","first-page":"1261","article-title":"Application of Chinese medical syndrome scores in effectiveness evaluation: a critical appraisal of 240 randomized controlled trials","volume":"35","author":"H. Luo","year":"2015","journal-title":"Chinese Journal of Integrated Traditional and Western Medicine"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1177\/030006059802600203"}],"container-title":["Evidence-Based Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/ecam\/2021\/5125568.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/ecam\/2021\/5125568.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/ecam\/2021\/5125568.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T23:02:07Z","timestamp":1633388527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/ecam\/2021\/5125568\/"}},"subtitle":[],"editor":[{"given":"Harry","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,10,4]]},"references-count":43,"alternative-id":["5125568","5125568"],"URL":"https:\/\/doi.org\/10.1155\/2021\/5125568","relation":{},"ISSN":["1741-4288","1741-427X"],"issn-type":[{"value":"1741-4288","type":"electronic"},{"value":"1741-427X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,4]]}}}